Xylo Technologies Ltd. (XYLO)
NASDAQ: XYLO · IEX Real-Time Price · USD
1.910
+0.040 (2.14%)
At close: May 17, 2024, 4:00 PM
1.830
-0.080 (-4.19%)
After-hours: May 17, 2024, 7:42 PM EDT
Xylo Technologies Market Cap
Xylo Technologies has a market cap or net worth of $3.57 million as of May 17, 2024. Its market cap has decreased by -67.29% in one year.
Market Cap
3.57M
Enterprise Value
-1.41M
1-Year Change
-67.29%
Ranking
Category
Stock Price
$1.91
Market Cap Chart
Since August 5, 2015, Xylo Technologies's market cap has decreased from $29.00M to $3.57M, a decrease of -87.70%. That is a compound annual growth rate of -21.22%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 3.60M | - |
May 16, 2024 | 3.60M | -5.26% |
May 15, 2024 | 3.80M | 8.57% |
May 14, 2024 | 3.50M | -2.78% |
May 13, 2024 | 3.60M | 9.09% |
May 10, 2024 | 3.30M | -2.94% |
May 9, 2024 | 3.40M | 3.03% |
May 8, 2024 | 3.30M | -8.33% |
May 7, 2024 | 3.60M | 20.00% |
May 6, 2024 | 3.00M | 7.14% |
May 3, 2024 | 2.80M | -12.50% |
May 2, 2024 | 3.20M | 3.23% |
May 1, 2024 | 3.10M | 3.33% |
Apr 30, 2024 | 3.00M | -3.23% |
Apr 29, 2024 | 3.10M | - |
Apr 26, 2024 | 3.10M | - |
Apr 25, 2024 | 3.10M | -20.51% |
Apr 24, 2024 | 3.90M | -7.14% |
Apr 23, 2024 | 4.20M | -10.64% |
Apr 22, 2024 | 4.70M | 9.30% |
Apr 19, 2024 | 4.30M | 7.50% |
Apr 18, 2024 | 4.00M | 2.56% |
Apr 17, 2024 | 3.90M | 8.33% |
Apr 16, 2024 | 3.60M | -2.70% |
Apr 15, 2024 | 3.70M | -9.76% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Clever Leaves Holdings | 3.70M |
TRACON Pharmaceuticals | 3.69M |
Phio Pharmaceuticals | 3.67M |
TC Biopharm (Holdings) | 3.58M |
Petros Pharmaceuticals | 3.55M |
Bio-Path Holdings | 3.51M |
Mustang Bio | 3.46M |
Altamira Therapeutics | 3.43M |